University of North Carolina, Chapel Hill: Hepatitis C trials

The registry lists 11 Hepatitis C studies with University of North Carolina, Chapel Hill as lead sponsor. 0 are open to participants now and 1 have results posted.

Phase 1 1No phase 10(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• The Patient-Reported Outcomes Project of HCV-TARGETCompletedNCT02601820Results posted
• Voices From the Black Community: Hepatitis C Research ParticipationCompletedNCT04202081
• Crowdsourcing to Promote HBV and HCV Testing in ChinaCompletedNCT03482388Not applicable
• Pilot Feasibility Study of a Cognitive Behavioral Coping Skills (CBCS) Group Intervention for Hep C Therapy PatientsCompletedNCT03057236Not applicable
• Anticipated and Perceived Benefits Following Hepatitis C TreatmentCompletedNCT03000023
• Evaluation of Serum Chemokines for Patients Undergoing Treatment With Boceprevir.WithdrawnNCT01949077
• The Pathogenesis of Hepatitis C Virus Vertical TransmissionCompletedNCT01921400
• HCV-TARGET- Hepatitis C Therapeutic Registry and Research NetworkCompletedNCT01474811
• Differences in Evoked Intracellular Interferon Signaling Pathways Using Single Cell Phosphoprotein ProfilingCompletedNCT01217359Phase 1
• Overcoming Psychiatric Barriers to the Treatment of Hepatitis CCompletedNCT00407732Not applicable
• Hepatitis C in Clinically Discordant Hemophilic SiblingsCompletedNCT00007371